Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05177406 · ClinicalTrials.gov registry record
Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data
A clinical trial, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- 1,839
- Enrollment target
NCT05177406 is a clinical trial that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 1,839 participants.
The verdict
NCT05177406 has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- 1,839 participants
- Enrollment target
Study Summary
The proposed study is a retrospective, non-interventional analysis that uses medical and pharmacy claims data in the US from Komodo Health
Interventions
- OTHER Aimovig
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,839 participants |
| Start Date | 2020-08-31 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05177406
The ClinicalTrials.gov registry entry for NCT05177406 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,839 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aimovig is the first listed.
NCT05177406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05177406 about?
NCT05177406 is a clinical study titled "Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data". The proposed study is a retrospective, non-interventional analysis that uses medical and pharmacy claims data in the US from Komodo Health
What is the current status of trial NCT05177406?
This trial is currently completed. The enrollment target is 1,839 participants. The study started on 2020-08-31. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT05177406?
The interventions under investigation include: Aimovig (OTHER).
Who is sponsoring clinical trial NCT05177406?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.